Evidence map›Paper›PMID 41964382›Full record

ReviewFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026

Human α2-Macroglobulin: Architecture, Mechanisms, and Functional Implications.

Pietro de Carvalho Andrade, Tales Alexandre Costa-Silva, Gisele Monteiro

Erratum issuedAbstract readReview
In one paragraph

Review in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Correction to "Human α2-Macroglobulin: Architecture, Mechanisms, and Functional Implications".FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Pietro de Carvalho AndradeDepartment of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0009-0001-3666-2298
Tales Alexandre Costa-SilvaCenter for Natural and Human Sciences, Federal University of ABC, Santo André, SP, Brazil.ORCID https://orcid.org/0000-0002-7814-9257
Gisele MonteiroDepartment of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-3385-047X

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 423532/2018-9Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) 001Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2022/02456-0
6 · The paper itself

Abstract

α2-Macroglobulin (α2M) is a large glycoprotein and one of the most abundant proteins found in the plasma of vertebrates and in the hemolymph of invertebrates. It performs several important functions in the innate immune system, serving as a pan-protease inhibitor and contributing to essential processes, such as cytokine and hormone transport. It also triggers diverse cellular responses, critical for the functioning of both eukaryotic and some prokaryotic biological systems. Here, we focus on the human α2-macroglobulin (hα2M) molecule, compiling relevant information from recent studies on its structure and how this relates to its unique protease capture mechanism. In addition, we summarize other findings accumulated over 50 years of literature on hα2M. We also discuss its distinctive electrophoretic behavior, its dimeric form, and its potential role in inflammatory environments, as well as the basic unit of hα2M for protease capture. We summarize some challenges encountered in hα2M structural studies, a distinctive mechanism of incorporation of non-proteolytic ligands, and remarks and details on its purification and storage. Although the clinical use of hα2M is currently limited mainly to its role as a secondary biomarker for certain disorders, new therapeutic approaches have begun to emerge in initial studies over the past decade. The study of hα2M remains highly relevant for understanding unknown aspects of the innate immune system, developing new therapies, elucidating infection and inflammation processes, exploring potential links to mechanisms of cancer resistance, and advancing other fields critically important to translational and clinical research.

Indexed as

alpha-MacroglobulinsAnimalsHumansImmunity, InnatePeptide HydrolasesPregnancy-Associated alpha 2-MacroglobulinsA2M protein, humanalpha-MacroglobulinsPeptide HydrolasesPregnancy-Associated alpha 2-Macroglobulinsalpha 2 macroglobulinmolecular mechanismsplasma proteinprotease inhibitorproteinase

Identifiers

PMID41964382
PMCPMC13069473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.